About this trial
This clinical trial aims to evaluate the effectiveness of interactive exergaming combined with Otago Exercise Program on mobility among community-dwelling older adults aged 65 and above. The main research questions are:
Does this combined exercise intervention improve elderly mobility? Does this program enhance muscle strength and psychological well-being?
Researchers will compare two groups: one group will do the combined exercise program for 12 weeks, while the other group will continue their usual activities.
Participants will:
* Have their health checked three times: at the start, after 12 weeks, and 3 months later * If in the exercise group, attend exercise sessions twice a week for 12 weeks * Complete tests about their physical abilities and how they feel emotionally
Who can take part:
* Adults age 65 or older * People who need more than 12 seconds to stand up and sit down 5 times * People who can stand for at least 30 seconds with support
People cannot take part if they have serious vision problems, recent leg injuries, major illnesses, significant memory problems, or mental health conditions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 65 years
Abnormal mobility based on ICOPE screening (Five-time chair stand test > 12 seconds)
Able to stand holding handrail for > 30 seconds
Disqualifiers
Severe visual impairment
Lower limb fracture
Acute serious illness
Moderate to severe cognitive impairment (SPMSQ > 5 errors)
Trial design
Parallel
Treatments tested in this trial
Interactive Exergaming with Otago Exercise Program
BehavioralParticipants will receive a 12-week structured program combining interactive exergaming and Otago Exercise Program. Sessions include balance training, strength exercises, and functional mobility activities delivered through interactive gaming platforms, supervised by trained instructors.
Control Group with Usual Care
Other interventionParticipants will maintain their regular activities at community centers or facilities, including cognitive therapy, oral exercises, and upper limb training programs, during the 12-week study period
Treatment groups
Trial outcomes
Primary outcomes
Mobility Performance
Measured by Short Physical Performance Battery (SPPB) Scale: 0-12 points, higher scores indicate better performance
Lower Extremity Strength
Measured by digital dynamometer Unit: Kilograms (kg)
Secondary outcomes
Intrinsic Capacity Score
omprehensive assessment of intrinsic capacity using Integrated Care for Older People (ICOPE) screening tool, measuring six domains: * Cognition (3 memory items and orientation questions) * Mobility (5-time sit-to-stand test) * Nutrition (weight loss and appetite assessment) * Vision (visual assessment) * Hearing (whisper test) * Depression (mood and interest assessment) For each domain, if any item within that domain is abnormal, the domain is scored as 0 (indicating risk of capacity decline); if all items are normal, the domain is scored as 1 (normal). Total score ranges from 0 (all domains at risk) to 6 (all domains normal), with higher scores indicating fewer domains at risk of capacity decline.
Loneliness Level
Three-Item Loneliness Scale (T-ILS) Assessment of loneliness using T-ILS. Scale: 3-9 points, lower scores indicate less loneliness
Depression Symptoms
Assessment of depression symptoms using Geriatric Depression Scale-5 (GDS-5). Scale: 0-5 points, lower scores indicate less depressive symptoms
Well-being Status
Assessment of well-being using 9-item Well-being Scale. Scale: 9-45 points, higher scores indicate better well-being.
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: